With profit at an eight-year high, pharmaceutical May & Baker Nigeria Plc reported a 56 percent growth despite high operation ...
With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia1 classed as 'zero dose', having never ...
The Save the Children Immunisation Accelerator, funded by GSK, has awarded two innovation projects for finding unique solutions to help more children receive vaccinations. With an estimated 2.1 ...
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug ...
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently undervalued according to InvestingPro Fair Value metrics, has reached a ...
EMA has accepted GSK’s application for a prefilled syringe presentation of Shingrix for review. Credit: Vivida Photo PC/Shutterstock. GSK and the University of Oxford have entered a new research ...
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...
UN Seeks $910 Million for Humanitarian Crisis in Nigeria's Northeast By Ope Adetayo ABUJA (Reuters) - The United Nations will this week appeal for $910 million to help tackle a humanitarian crisis ...
THE United Nations (UN) has set plans to secure $910 million this week to help tackle a humanitarian crisis in northeastern Nigeria. Reuters revealed this in a report on Wednesday, January 22, hinting ...
Credit: megaflopp/Shutterstock. The European Commission (EC) has approved GSK’s Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results